CRIS Current Research Information System

ZUFFA, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.887
AS - Asia 1.784
EU - Europa 1.445
AF - Africa 105
SA - Sud America 72
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 5.299
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.852
VN - Vietnam 562
SG - Singapore 493
CN - Cina 399
GB - Regno Unito 361
SE - Svezia 213
DE - Germania 197
IT - Italia 172
FR - Francia 98
HK - Hong Kong 86
UA - Ucraina 83
IN - India 71
RU - Federazione Russa 67
NL - Olanda 65
IE - Irlanda 51
BR - Brasile 47
JP - Giappone 44
TG - Togo 30
ZA - Sudafrica 30
FI - Finlandia 29
EE - Estonia 27
CA - Canada 25
NG - Nigeria 22
BD - Bangladesh 20
KR - Corea 19
BG - Bulgaria 15
JO - Giordania 15
PH - Filippine 14
BE - Belgio 12
AR - Argentina 10
CI - Costa d'Avorio 10
IQ - Iraq 9
PL - Polonia 9
TH - Thailandia 9
PK - Pakistan 8
CH - Svizzera 7
MX - Messico 7
AT - Austria 6
ES - Italia 6
HR - Croazia 6
SC - Seychelles 6
EC - Ecuador 5
PY - Paraguay 5
TR - Turchia 5
GR - Grecia 4
ID - Indonesia 4
IR - Iran 4
RO - Romania 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
LT - Lituania 3
MY - Malesia 3
SA - Arabia Saudita 3
CL - Cile 2
DK - Danimarca 2
LV - Lettonia 2
NP - Nepal 2
SN - Senegal 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CO - Colombia 1
ET - Etiopia 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 5.299
Salva come PNG Salva come JPEG
Città #
Singapore 353
Southend 322
Ashburn 220
Dong Ket 201
Chandler 179
Fairfield 117
San Jose 114
Ho Chi Minh City 94
Ann Arbor 92
Hanoi 83
Hong Kong 80
Beijing 74
Seattle 73
Wilmington 73
Houston 67
Woodbridge 66
Princeton 58
Dublin 51
Jacksonville 47
Boardman 46
Santa Clara 46
Cambridge 42
Tokyo 42
New York 39
Lomé 30
Padova 30
Hefei 29
Lauterbourg 29
Los Angeles 29
Westminster 29
Nanjing 27
Bologna 24
Helsinki 22
Medford 22
Munich 20
Berlin 19
Jinan 19
Abeokuta 17
Frankfurt am Main 17
Milan 17
Amman 15
Council Bluffs 15
Sofia 15
Changsha 13
Haiphong 13
Saint Petersburg 13
Brussels 12
Toronto 12
Seoul 11
Abidjan 10
Bremen 10
Da Nang 10
Redondo Beach 10
Hebei 9
Shanghai 9
Falkenstein 8
Guangzhou 8
São Paulo 8
Buffalo 7
Hải Dương 7
Jiaxing 7
Orem 7
Paris 7
Redwood City 7
Shenyang 7
Falls Church 6
Nanchang 6
Romainville 6
San Diego 6
Turin 6
Turku 6
Atlanta 5
Baghdad 5
Brooklyn 5
Bühl 5
Hangzhou 5
Mountain View 5
Mülheim 5
Shijiazhuang 5
Xi'an 5
Zhengzhou 5
Bangkok 4
Bern 4
Bến Tre 4
Chengdu 4
Dallas 4
Dearborn 4
Düsseldorf 4
Florence 4
Johannesburg 4
Kunming 4
Long Xuyen 4
Montreal 4
Norwalk 4
Rome 4
Stockholm 4
Tianjin 4
Verona 4
Vienna 4
Wroclaw 4
Totale 3.371
Salva come PNG Salva come JPEG
Nome #
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 288
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 275
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 251
NEW STRATEGIES IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA. COMBINED USE OF SRC AND TYROSINE KINASE INHIBITORS CIRCUMVENTS THE DEVELOPMENT OF DRUG-RESISTANCE 232
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 229
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 213
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities 210
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 206
Apoptotic death of Bcr-Abl-expressing myeloid progenitors in response to the m-Tor inhibitor RAD001 (Everolimus) is promoted by the nuclear import of c-Abl 191
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 189
P210 Bcr-abl tyrosine kinase interaction with histone deacetylase 1 modifies histone H4 acetylation and chromatin structure of chronic myeloid leukaemia haematopoietic progenitors 188
The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study 186
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 183
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 178
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 178
HDAC1 (histone deacetylase1) involvement in Chronic Myeloid Leukemia 177
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 174
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients 173
Persistent Cdk2 inactivation drives growth arrest of BCR-ABL-expressing cells in response to dual inhibitor of SRC and ABL kinases SKI606 172
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 161
Evaluation of the Diasorin Q-Lamp technology for the molecular diagnosis of the philadelphia positive leukemias: an italian multicenter study 160
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 159
Genomic imbalances associated with secondary acute leukemias in Hodgkin lymphoma. 158
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 152
The m-TOR inhibitor everolimus complements pro-apoptotic and anti-proliferative effects of imatinib on chronic myeloid leukemia progenitors by promoting the nuclear import of normal c-Abl protein 149
Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients 146
Genomic instability in the development of non-Hodgkin lymphomas secondary to Hodgkin lymphoma 142
Post-translational modifications of FOXO3a transcription factor associated with the constitutive tyrosine kinase activity of p210 BCR-ABL protein. Implications for new targeted therapies 130
P210 BCR-ABL tyrosine kinase prevents apoptotic cell death through multiple pathways converging at mitochondrial membranes 128
Totale 5.378
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.230
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.230
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022592 31 15 36 66 55 32 16 26 27 41 124 123
2022/2023710 98 97 47 90 50 58 15 35 116 22 50 32
2023/2024193 4 31 5 34 14 53 14 9 7 8 7 7
2024/2025648 11 102 57 51 75 23 67 27 6 84 18 127
2025/20261.634 141 92 111 91 248 93 129 42 431 143 48 65
2026/202716 16 0 0 0 0 0 0 0 0 0 0 0
Totale 5.378